Latest Competition News

Iluka Resources reported a 32% drop in net profit after tax to $231 million for 2024, while securing critical funding for its Eneabba rare earths refinery and progressing the Balranald mine development.

EBOS Group Limited announces the retirement of CEO John Cullity after a decade of strong growth, appointing Adam Hall as his successor to lead the company’s next phase of expansion.

EBOS Group Limited’s interim results for H1 2025 reveal a notable decrease in revenue and profit compared to the prior year, yet the company maintains its interim dividend, signaling confidence despite headwinds.

Fletcher Building reported a challenging HY25 with a 7% revenue decline and a net loss of NZ$134 million, while executing a $700 million equity raise to strengthen its balance sheet and advancing significant cost reduction initiatives.

MyState Limited has reported a stable underlying net profit of $17.5 million for the half-year, maintaining customer growth and a robust capital position as it prepares to merge with Auswide Bank.

Mystate Limited has announced a fully franked ordinary dividend of AUD 0.105 per share for the six months ending December 31, 2024, payable on March 21, 2025. The company’s Dividend Reinvestment Plan remains active, offering shareholders a discounted reinvestment option.

MyState Limited reported a modest revenue increase but an 8.9% decline in statutory profit for the half year ended December 2024, while declaring a fully franked interim dividend. The company is set to complete a transformative merger with Auswide Bank, aiming for earnings accretion from FY26.

Brisbane Broncos Limited has announced a fully franked ordinary dividend of AUD 0.02 per share for the 2024 financial year, signaling steady returns for shareholders.

Brisbane Broncos Limited reported a solid $5.72 million net profit for 2024, underpinned by revenue growth and a decade-long extension to their NRL Club Licence. Despite missing the NRL finals, commercial strength and NRLW success buoyed the club's financial position.

Ardea Resources Limited has made significant progress on its Kalgoorlie Nickel Project (KNP) Goongarrie Hub, supported by a fully funded $98.5 million Definitive Feasibility Study (DFS) led by a Japanese consortium. The project is positioned as a long-life, low-cost nickel-cobalt operation critical to the global battery supply chain.

Nyrada Inc. posted a significant $2.46 million loss for H1 FY25, driven by increased R&D spend, while advancing its lead drug NYR-BI03 into first-in-human trials following regulatory approval.

Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.